GB Patent

GB0325956D0 — Novel compounds

Assigned to Addex Pharmaceuticals SA · Expires 2003-12-10 · 22y expired

What this patent protects

The present invention relates to new compounds of formula (I) wherein A, B, P, Q,W, R 1 and R 2 are defined in the description; invention compounds are useful in the prevention or treatment of central nervous system disorders as well as other disorders modulated by mGluR5 recep…

USPTO Abstract

The present invention relates to new compounds of formula (I) wherein A, B, P, Q,W, R 1 and R 2 are defined in the description; invention compounds are useful in the prevention or treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.

Drugs covered by this patent

Patent Metadata

Patent number
GB0325956D0
Jurisdiction
GB
Classification
—
Expires
2003-12-10
Drug substance claim
No
Drug product claim
No
Assignee
Addex Pharmaceuticals SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.